{
    "nctId": "NCT03148015",
    "briefTitle": "Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)",
    "officialTitle": "Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Molecular and Histopathologic Characteristics",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must be female, at least 18 years of age.\n* Patients or their legally authorized representative must have signed and dated an informed consent form\n* Patients must have at minimum, adequate samples of breast tissue available for use in this study.\n* Patients with a tissue diagnosis of low, intermediate or high grade ductal carcinoma in situ or ductal carcinoma in situ with microinvasion.\n* Patients with a diagnosis of atypical ductal hyperplasia, lobular cancer in situ or any preinvasive breast lesion.\n* Patients with ductal carcinoma in situ undergoing either lumpectomy and radiation or mastectomy.\n* Patients with a diagnosis of invasive ductal cancer.\n\nExclusion Criteria:\n\n* Male.\n* Patients under the age of 18 or over the age of 89.\n* Patient desires not to participate in the study.\n* Inability to consent.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}